Developing Viral Vaccines for Emerging Infectious Diseases

Developing Viral Vaccines for Emerging Infectious Diseases

Innovative new technologies support and accelerate vaccine discovery to help combat new and emerging pathogens

Written byLab Manager
| 1 min read

The recent global outbreak of a novel pandemic COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), reminds us of the constant need for continued vaccine development as viral threats evolve. Unprecedented efforts and collaborations in the scientific community are underway to develop a vaccine. 

See how Sartorius’ innovative solutions advance and accelerate discovery and development of new vaccines against viral infections!

Access this free infographic, compliments of Sartorius.

Add Lab Manager as a preferred source on Google

Add Lab Manager as a preferred Google source to see more of our trusted coverage.

Related Topics

Loading Next Article...
Loading Next Article...

CURRENT ISSUE - January/February 2026

How to Build Trust Into Every Lab Result

Applying the Six Cs Helps Labs Deliver Results Stakeholders Can Rely On

Lab Manager January/February 2026 Cover Image